BOSTON, April 7, 2025 /PRNewswire/ -- Kezar Markets, LLC, owner of the broker-dealer operator of the LeveL and Luminex Alternative Trading Systems, today announced its rebranding transition and ...

Kezar Markets, LLC, owner of the broker-dealer operator of the LeveL and Luminex Alternative Trading Systems, announced its rebranding transition and new visual identity to LeveL Markets, LLC, ...

Kezar Life Sciences (NASDAQ:KZR) traded lower on Tuesday after the company announced its Q4 2024 financial results alongside data from a mid-stage trial for its lead asset zetomipzomib in patients ...

The Many Voices Summit on April 21 will feature workshops led by Adrianna Kezar, dean’s professor of leadership, Wilbur-Kieffer Professor of Higher Education and director of the Pullias Center for ...

KEZAR LIFE SCIENCES ($KZR) posted quarterly earnings results on Tuesday, March 25th. The company reported earnings of -$2.77 per share, beating estimates of -$2.91 by ...

My name is Mitchell, and I will be your conference operator today. At this time, I would like to welcome you to Kezar Life Sciences 2025 Topline Data Presentation of the PORTOLA Phase 2a Clinical ...

Kezar Life Sciences (KZR) reported topline results from the PORTOLA Phase 2a clinical trial evaluating zetomipzomib, a selective immunoproteasome inhibitor, in patients with autoimmune hepatitis ...